Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 260,006Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Strides Pharma Science

02 1Avenza Pharmaceuticals

03 1Centurion Laboratories

04 2Cristalia Produtos Quimicos Farma. Ltda

05 1Mirpharm

06 1Pantson Pharma Pvt. Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Regulatory Info :

Registration Country : India

Cabergoline

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Packaging :

Regulatory Info :

Cabergoline

Dosage : Tablet

Dosage Strength : 0.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Strides Pharma Science

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

CPhI India 2024
Not Confirmed
arrow

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Dosage : Tablet

Dosage Strength : 0.5mg

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Brand Name : CABEREDUZ

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 1 BOTTLE X 2

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Brazil

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Dosage : TABLET

Dosage Strength : 0.5MG

Brand Name : CABEREDUZ

Approval Date :

Application Number :

Registration Country : Brazil

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Brand Name : CABEREDUZ

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 1 BOTTLE X 8

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Brazil

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Dosage : TABLET

Dosage Strength : 0.5MG

Brand Name : CABEREDUZ

Approval Date :

Application Number :

Registration Country : Brazil

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Russia

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Dosage : Tablet

Dosage Strength : 0.5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Russia

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Cabergoline

Brand Name :

Dosage Form : Tablet

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

CPhI India 2024
Not Confirmed
arrow